MedTrace Logo

Tablet-based Aphasia Therapy in the Chronic Phase

NCT03622411 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2023-01-10

No results posted yet for this study

Summary

Aphasia is one of the most common and disabling disorders following stroke, in many cases resolving in long-term deficits. There is evidence that intensive aphasia therapy is effective for language recovery, even in the chronic phase post-stroke. However, as many patients are left with residual language disorders and intensive aphasia rehabilitation is difficult to achieve, the investigators are exploring tablet-based therapies to further facilitate language recovery in a cost-effective manner.

Conditions

Interventions

DEVICE

speech app

language exercises provided by the speech therapist in hospital + independent practice of language exercises via a tablet and speech app

DEVICE

brain games

language exercises provided by the speech therapist in hospital + independent recreational tablet use via brain games

BEHAVIORAL

aphasia therapy

language exercises provided by the speech therapist in hospital

Sponsors & Collaborators

  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • Veerle De Herdt · University Ghent

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-07
Primary Completion
2021-02-23
Completion
2021-02-23

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03622411 on ClinicalTrials.gov